Table 2.
Demographic and clinical characteristics of participants and non-participants in the 2019 Alaska cancer survivors needs assessment survey (N = 2,452)
| Eligible non-participants (N = 2,117) | Participants (N = 335) | p value† | |||
|---|---|---|---|---|---|
| % | n | % | n | ||
| Diagnosis age, years | 0.74 | ||||
| Mean (SD) | 57.1 (12.9) | 56.8 (11.0) | |||
| Range (min–max) | 18–94 | 21–82 | |||
| Gender | 0.02 | ||||
| Male | 46.4 | 982 | 39.7 | 133 | |
| Female | 53.6 | 1,134 | 60.3 | 202 | |
| Race* | 0.01 | ||||
| Alaska Native/American Indian | 11.9 | 251 | 10.8 | 36 | |
| White | 78.7 | 1,665 | 84.2 | 282 | |
| Other | 8.5 | 179 | 3.3 | 11 | |
| Unknown | 1.0 | 22 | 1.8 | 6 | |
| Diagnosis year | 0.75 | ||||
| 2004 | 7.8 | 166 | 7.8 | 26 | |
| 2005 | 8.1 | 171 | 6.3 | 21 | |
| 2006 | 7.8 | 165 | 6.9 | 23 | |
| 2007 | 7.9 | 168 | 7.5 | 25 | |
| 2008 | 8.1 | 171 | 6.0 | 20 | |
| 2009 | 7.8 | 165 | 7.5 | 25 | |
| 2010 | 7.8 | 164 | 7.2 | 24 | |
| 2011 | 7.4 | 156 | 9.0 | 30 | |
| 2012 | 7.1 | 151 | 9.0 | 30 | |
| 2013 | 7.7 | 162 | 7.2 | 24 | |
| 2014 | 7.7 | 162 | 8.1 | 27 | |
| 2015 | 7.3 | 154 | 9.9 | 33 | |
| 2016 | 7.7 | 162 | 8.1 | 27 | |
| Laterality | 0.02 | ||||
| Not a paired site | 56.4 | 1,194 | 48.4 | 162 | |
| Right | 22.0 | 466 | 23.9 | 80 | |
| Left | 19.8 | 420 | 27.2 | 91 | |
| One side, R/L unspecified | 0.3 | 7 | 0.0 | < 5 | |
| Bilateral | 0.2 | < 5 | 0.0 | < 5 | |
| Undefined | 1.2 | 26 | 0.6 | < 5 | |
| Site | < 0.001 | ||||
| Breast | 24.0 | 507 | 34.6 | 116 | |
| Prostate | 18.3 | 388 | 18.2 | 61 | |
| All other | 57.7 | 1,222 | 47.2 | 158 | |
| Behavior | 0.37 | ||||
| In situ | 11.5 | 244 | 9.9 | 33 | |
| Malignant | 88.5 | 1,873 | 90.2 | 302 | |
Source Alaska Cancer Registry (ACR) data
†For age p value is a t test; for other categories p value is from a chi-square
*Only one race is included in the ACR; ethnicity is not included